Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06820359 · ClinicalTrials.gov registry record · NA
Bowel Preparation in Minimally Invasive Gynecologic Surgery
A NA study of Gynecologic Disease, sponsored by Muhammad Aslam.
- Recruiting
- Registry status
- NA
- Development phase
- 166
- Enrollment target
- 2
- Study locations
NCT06820359 is a NA study of Gynecologic Disease that is actively recruiting participants, run by Muhammad Aslam. The registered enrollment target is 166 participants, above the 54-participant average among 3 other Gynecologic Disease trials with a reported enrollment target (207% higher). The trial reports 2 study locations across 1 state.
The verdict
NCT06820359, a NA study of Gynecologic Disease, is actively recruiting participants, sponsored by Muhammad Aslam.
- RECRUITING
- Registry status
- NA
- Development phase
- 166 participants
- Enrollment target
- 2
- Study locations
Study Summary
This is a prospective randomized study of patients who are scheduled to undergo minimally invasive robotic gynecologic surgery. Patients will be randomized to require either pre-surgical bowel preparation vs. no bowel preparation. The effect of bowel preparation on intraoperative visualization, bowel handling, intestinal load and ease of surgery will be assessed. Patient comfort and satisfaction will be assessed.
Conditions Studied
Interventions
- OTHER Bowel Preparation
- OTHER No bowel preparation
Study Locations (2)
Michigan
- Henry Ford St. John Hospital - Detroit
- Henry Ford Macomb-Oakland Hospital, Warren Campus - Warren
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 166 participants |
| Start Date | 2025-02-17 |
| Est. Completion | 2026-01-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06820359
The ClinicalTrials.gov registry entry for NCT06820359 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 166 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 54-participant average among 3 other Gynecologic Disease trials with a reported enrollment target (207% higher). The listed sponsor is Muhammad Aslam, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Gynecologic Disease appearing as the primary indexed condition, and to 2 interventions - of which Bowel Preparation is the first listed.
NCT06820359 reports 2 study locations spanning 1 distinct geographic area - top geographies include Michigan.
Frequently Asked Questions
What is clinical trial NCT06820359 about?
NCT06820359 is a clinical study titled "Bowel Preparation in Minimally Invasive Gynecologic Surgery". This is a prospective randomized study of patients who are scheduled to undergo minimally invasive robotic gynecologic surgery. Patients will be randomized to require either pre-surgical bowel preparation vs. no bowel preparation. The effect of bowel preparation on intraoperative visualization, bowe...
What is the current status of trial NCT06820359?
This trial is currently recruiting. It is a NA study. The enrollment target is 166 participants. The study started on 2025-02-17. Estimated completion is 2026-01-31.
What conditions does trial NCT06820359 study?
This clinical trial studies the following conditions: Gynecologic Disease.
What interventions are being tested in trial NCT06820359?
The interventions under investigation include: Bowel Preparation (OTHER), No bowel preparation (OTHER).
Who is sponsoring clinical trial NCT06820359?
This trial is sponsored by Muhammad Aslam, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06820359 being conducted?
This trial has 2 study locations across Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Gynecologic Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.